{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:51:11Z","timestamp":1793825471401,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["SPCR, grant number 259"],"award-info":[{"award-number":["SPCR, grant number 259"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12916-017-0987-1","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T11:21:31Z","timestamp":1515496891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-2986","authenticated-orcid":false,"given":"Zoe","family":"Paskins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyshah Abdul","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Blagojevic-Bucknall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Helliwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Hider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"issue":"15","key":"987_CR1","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1097\/MD.0000000000000647","volume":"94","author":"L Fardet","year":"2015","unstructured":"Fardet L, Petersen I, Nazareth I. Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study. Medicine (Baltimore). 2015;94(15):e647.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"987_CR2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","volume":"13","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol. 2017;13(10):578\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"987_CR3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"T Staa Van","year":"2000","unstructured":"Van Staa T, Leufkens H, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15(6):993\u20131000.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"987_CR4","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"T Staa Van","year":"2006","unstructured":"Van Staa T, Geusens P, Bijlsma J, Leufkens H, Cooper C. Clinical assessment of the long\u2010term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheumatism. 2006;54(10):3104\u201312.","journal-title":"Arthritis Rheumatism"},{"issue":"4","key":"987_CR5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00198-013-2587-z","volume":"25","author":"I Bultink","year":"2014","unstructured":"Bultink I, Harvey N, Lalmohamed A, et al. Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the united kingdom. Osteoporosis Int. 2014;25(4):1275\u201383.","journal-title":"Osteoporosis Int"},{"issue":"6","key":"987_CR6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2003.09.027","volume":"125","author":"T Staa Van","year":"2003","unstructured":"Van Staa T, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology. 2003;125(6):1591\u20137.","journal-title":"Gastroenterology"},{"issue":"8","key":"987_CR7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford). 2010;49(8):1594\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"987_CR8","first-page":"69A75","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Methotrexate, azathioprine, cyclosporine, and risk of fracture. Calcif Tissue Int. 2006;79:69A75.","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"987_CR9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.52.8.582","volume":"52","author":"SJ Preston","year":"1993","unstructured":"Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis. 1993;52(8):582\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"9313","key":"987_CR10","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"HK Choi","year":"2002","unstructured":"Choi HK, Hern\u00e1n MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359(9313):1173\u20137.","journal-title":"Lancet"},{"issue":"1","key":"987_CR11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford). 2010;49(1):186\u201390.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"987_CR12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.semarthrit.2016.10.001","volume":"46","author":"JC Wilson","year":"2017","unstructured":"Wilson JC, Sarsour K, Collinson N, Tuckwell K, Musselman D, Klearman M, Napalkov P, Jick SS, Stone JH, Meier CR. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis. Semin Arthritis Rheum. 2017;46(5):650\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"987_CR13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4081\/reumatismo.2017.922","volume":"69","author":"M Rossini","year":"2017","unstructured":"Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Bongi SM, Di Munno O, Nuti R, Manzini CU, Ferri C, Bogliolo L. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo. 2017;69(1):30\u20139.","journal-title":"Reumatismo"},{"issue":"2","key":"987_CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","volume":"39","author":"A Angeli","year":"2006","unstructured":"Angeli A, Guglielmi G, Dovio A, et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone. 2006;39(2):253\u20139.","journal-title":"Bone"},{"issue":"3","key":"987_CR15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3899\/jrheum.110851","volume":"39","author":"M Mazzantini","year":"2012","unstructured":"Mazzantini M, Torre C, Miccoli M, et al. Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol. 2012;39(3):552\u20137.","journal-title":"J Rheumatol"},{"issue":"8","key":"987_CR16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/ard.48.8.662","volume":"48","author":"V Kyle","year":"1989","unstructured":"Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. II. relation between steroid dose and steroid associated side effects. Ann Rheum Dis. 1989;48(8):662\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"987_CR17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"987_CR18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","volume":"14","author":"JD Lewis","year":"2005","unstructured":"Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf. 2005;14(7):443\u201351.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"987_CR19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"J Kanis","year":"2008","unstructured":"Kanis J, Johnell O, Od\u00e9n A, Johansson H, McCloskey E. FRAX\u2122 and the assessment of fracture probability in men and women from the UK. Osteoporosis Int. 2008;19(4):385\u201397.","journal-title":"Osteoporosis Int"},{"issue":"5","key":"987_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/1099-1557(200009\/10)9:5<359::AID-PDS507>3.0.CO;2-E","volume":"9","author":"T Staa Van","year":"2000","unstructured":"Van Staa T, Abenhaim L, Cooper C, Zhang B, Leufkens H. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf. 2000;9(5):359\u201366.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"987_CR21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"2","key":"987_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","volume":"7","author":"C Cooper","year":"1992","unstructured":"Cooper C, Atkinson EJ, O'Fallon MW, Melton JL. Incidence of clinically diagnosed vertebral fractures: a population\u2010based study in Rochester, Minnesota, 1985\u20101989. J Bone Miner Res. 1992;7(2):221\u20137.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"987_CR23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","volume":"65","author":"L Smeeth","year":"2006","unstructured":"Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the united kingdom, 1990-2001. Ann Rheum Dis. 2006;65(8):1093\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"987_CR24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13075-016-1097-8","volume":"18","author":"S Muller","year":"2016","unstructured":"Muller S, Hider SL, Helliwell T, et al. Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR cohort study. Arthritis Res Ther. 2016;18(1):200.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"987_CR25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/ard.62.4.350","volume":"62","author":"IW Chantler","year":"2003","unstructured":"Chantler IW, Davie MW, Evans SF, Rees JS. Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service. Ann Rheum Dis. 2003;62(4):350\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"987_CR26","doi-asserted-by":"crossref","first-page":"e000095","DOI":"10.1136\/rmdopen-2015-000095","volume":"1","author":"P Das","year":"2015","unstructured":"Das P, Samanta A, Dasgupta B. Balancing on the edge: implications of a UK national audit of the use of BSR-BHPR guidelines for the diagnosis and management of polymyalgia rheumatica. RMD Open. 2015;1(1):e000095.","journal-title":"RMD Open"},{"key":"987_CR27","volume-title":"Glucocorticoid-Induced Osteoporosis: Guidelines for Prevention and Treatment","author":"Bone and Tooth Society","year":"2002","unstructured":"Bone and Tooth Society, Royal College of Physicians of London. Glucocorticoid-Induced Osteoporosis: Guidelines for Prevention and Treatment. London: Royal College of Physicians; 2002."},{"key":"987_CR28","unstructured":"National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summary: Giant Cell Arteritis. 2014. \nhttps:\/\/cks.nice.org.uk\/giant-cell-arteritis\n\n. Accessed 2 Feb 2017."},{"key":"987_CR29","unstructured":"National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summary: Polymyalgia Rheumatica. 2013. \nhttps:\/\/cks.nice.org.uk\/polymyalgia-rheumatica\n\n. Accessed 2 Feb 2017."},{"key":"987_CR30","volume-title":"Polymyalgia Rheumatica in Primary Care: An Exploration of the Challenges of Diagnosis and Management Using Survey and Qualitative Methods. PhD Thesis","author":"T Helliwell","year":"2016","unstructured":"Helliwell T. Polymyalgia Rheumatica in Primary Care: An Exploration of the Challenges of Diagnosis and Management Using Survey and Qualitative Methods. PhD Thesis. Staffordshire: Keele University; 2016."},{"key":"987_CR31","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, et al. Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74:1799\u2013807.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-017-0987-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T11:22:04Z","timestamp":1515496924000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-017-0987-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1186\/s12916-017-0987-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"article-number":"4"}}